UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Survey what’s included in dividend ETF fees, from management costs to trading and other ancillary charges that affect net returns.
11,381 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
When a well-known investment advisor unloads a large slice of a stock, it sparks questions. This guide breaks down wh...
Grocery Outlet GO's Q4 2025 earnings transcript sheds light on margin discipline, expansion plans, and the path to 20...
Equity traders watched the airline sector surge as oil prices fell and summer demand picked up. American Airlines led...
Bank of America's Vivek Arya sees Nvidia climbing to $350 as AI-driven demand sustains a broad, structural shift in c...
Box Inc is set to release Q1 results after the bell, with investors watching AI monetization progress and insider sel...
AVX's Q4 2025 results shed light on growth, profitability, and the path ahead. This article breaks down the numbers, ...
Drones and government funding chatter are reshaping investor sentiment. Ondas is at the center of the action, with ot...
Shares in American Eagle Outfitters slid after a disappointing quarterly report. This guide breaks down the key drive...
When a stock climbs 250% in a year, funds often trim positions to lock in gains and manage risk. This article explain...
Nautilus' early 2026 results could signal demand for home fitness gear and pricing power. This analysis breaks down t...
In May, apple stock soared about 15% as tech markets warmed to AI opportunities and Apple demonstrated a strong hardw...